Coronavirus pandemic continues wreaking havoc worldwide. According to worldometer.com, a total of 211,038,704 cases have been reported so far. Of these, 188,952,697 people have recovered, while 4,421,383 people have died.
US Pharmaceutical giant Johnson & Johnson has submitted an application to the Central Drugs Standard Control Organization (CDSCO), seeking permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group. The company's single-shot vaccine has shown an 85 percent efficacy in protection against severe disease in phase 3 clinical trials.
At the same time, the US pharma giant said it had submitted its application on Tuesday. It is imperative that all sections, including children should vaccinate against the coronavirus at the earliest. The company said that we remain deeply committed to the important work needed to make our COVID-19 vaccine equally accessible to all age groups. Meanwhile, Union Health Minister Mansukh Mandaviya had said on Thursday that COVID-19 vaccines for children would be available very soon. He said two other clinical trials conducted by Bharat Biotech and Zydus Cadila are already underway and their results are likely next month.
India has been witnessing a gradual decrease in daily coronavirus cases. According to the latest data from the Union Health Ministry, India reported 36,571 new coronavirus cases in the last 24 hours taking the cumulative count of the cases to 3,23,58,829. With 540 deaths in the last 24 hours, the death toll has increased to 4,33,589.
The country also witnessed 36,555 recoveries in the last 24 hours taking the cumulative recoveries to 3,15,61,635. With this, the country's recovery rate has increased to 97.53 %. On the other hand, India's mortality rate stands at 1.34 %.
Like and Follow us on :